VBI Vaccines CEO Jeffrey Baxter's 2023 pay falls 51% to $894K
VBI Vaccines reports 2023 executive compensation
By ExecPay News
Published: April 29, 2024
VBI Vaccines reported fiscal year 2023 executive compensation information on April 29, 2024.
In 2023, three executives at VBI Vaccines received on average a compensation package of $669K, a 48% decrease compared to previous year.
Average pay of disclosed executives at VBI Vaccines
Jeffrey R. Baxter, Chief Executive Officer, received $894K in total, which decreased by 51% compared to 2022. 78% of Baxter's compensation, or $698K, was in salary. Baxter also received $122K in option awards and $74K in other compensation.
David E. Anderson, Chief Scientific Officer, received a compensation package of $565K, which decreased by 43% compared to previous year. 81% of the compensation package, or $458K, was in salary.
Francisco Diaz-Mitoma, Chief Medical Officer, earned $549K in 2023, a 45% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2024.